LivaNova (LIVN) Current Deferred Tax Assets (2015)

Name: LivaNova (LIVN) Current Deferred Tax Assets (2015) | Business Quant
Creator: Business Quant

LivaNova recorded quarterly Current Deferred Tax Assets of $4.4 million in Q4 2015, down 39.14% quarter-over-quarter from $7.2 million in Q2 2015.

LivaNova's Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $4.4 million for Q4 2015.

In Q4 2015, Current Deferred Tax Assets changed N/A year-over-year to $4.4 million; the TTM figure through Oct 2015 stood at $4.4 million (changed N/A YoY), while the FY2015 annual figure was $7.2 million, changed N/A from the prior year.
Current Deferred Tax Assets came in at $4.4 million for Q4 2015 at LivaNova, down from $7.2 million in the prior quarter.
In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 million in Q2 2015 to a low of $4.4 million in Q4 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	LivaNova	4.03 Bn	3.45 Bn	243.75 Mn

Download Data 🔒